However, to fully utilize cfDNA for diagnostic reasons, it must be efficiently isolated from the bloodstream. Magnetic bead-based extraction methods may now extract PCR-amplifiable and ...

Please provide your email address to receive an email when new articles are posted on . Biopsies with high donor-derived cell-free DNA levels were likely to reveal antibody-mediated rejection.

Ebihara Takashi has been the chief operating officer of GeneFrontier (GFC) since 2010, with a focus on advancing cell-free protein expression technologies, particularly the PURE system. He earned a ...